E2F3 and colorectal carcinoma: CircPRTM5 exerts critical role in CRC by sponging miR‐377 to induce E2F3 expression and promoting cyclinD1 and CDK2 expression, which opens up a new insight into the potential treatment methods of CRC in humans.